BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8313228)

  • 1. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
    Rodrigues B; Braun JE; Spooner M; Severson DL
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of myocardial lipoprotein lipase activity by diabetes and thyroid hormones.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1994 Nov; 72(11):1259-64. PubMed ID: 7767864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
    Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
    Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
    Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
    Sambandam N; Lim F; Cam MC; Rodrigues B
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):110-7. PubMed ID: 9268229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE; Severson DL
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of clearing factor lipase (lipoprotein lipase) in vivo and from isolated perfused hearts of alloxan diabetic rats.
    Aktin E; Meng HC
    Diabetes; 1972 Mar; 21(3):149-56. PubMed ID: 5011980
    [No Abstract]   [Full Text] [Related]  

  • 14. Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy.
    Rodrigues B; Cam MC; Kong J; Goyal RK; McNeill JH
    Cardiovasc Res; 1997 Apr; 34(1):199-205. PubMed ID: 9217891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diabetes on acid and neutral triacylglycerol lipase and on lipoprotein lipase activities in isolated myocardial cells from rat heart.
    Ramírez I; Severson DL
    Biochem J; 1986 Aug; 238(1):233-8. PubMed ID: 3800935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma.
    Kaysen GA; Pan XM; Couser WG; Staprans I
    Am J Kidney Dis; 1993 Jul; 22(1):128-34. PubMed ID: 8322775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lipoprotein lipase activity in heart myocytes and perfused hearts.
    Bagby GJ; Corll CB
    J Mol Cell Cardiol; 1989 Mar; 21(3):253-62. PubMed ID: 2746652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-independent release of lipoprotein lipase activity from perfused rat hearts.
    Bagby GJ
    Biochim Biophys Acta; 1983 Aug; 753(1):47-52. PubMed ID: 6882786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
    Sambandam N; Abrahani MA; Craig S; Al-Atar O; Jeon E; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1874-82. PubMed ID: 10843884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hormones, amino acids and specific inhibitors on rat heart heparin-releasable lipoprotein lipase and tissue neutral lipase activities during long-term perfusion.
    Stam H; Hülsmann WC
    Biochim Biophys Acta; 1984 Jun; 794(1):72-82. PubMed ID: 6375731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.